This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
D3_AB_DEF_NORMHYPERIG
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
43 |
4. Check minimum number of eventsNone |
43 |
5. Include endpointsNone |
43 |
6. Filter based on genotype QC (FinnGen only) |
43 |
Control definitions (FinnGen only)
- Control exclude
- D3_IMMUNEMECHANISM
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D80
- Name in latin
- Deficientia immunalis cum quantitate immunoglobulini prope normali sive cum hyperimmunoglobulinaemia
Similar endpoints
↥List of similar endpoints to
Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
based on the number of shared cases.
Similar with more cases:
- Immunodeficiency with predominantly antibody defects
- Immunodeficiencies
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 159 | 110 | 48 |
| Only index persons | 151 | 105 | 46 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 42.06 | 42.96 | 39.86 |
| Only index persons | 41.98 | 42.90 | 39.86 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 43 | 31 | 12 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 43.73 | 46.07 | 37.66 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4062490)
15
0
+∞
16.73
1.8
0.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
21
33
11.48
14.35
3.4
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
21
36
10.45
13.28
4.3
2.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
18
29
9.96
11.82
2.4
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
35
116
11.77
11.54
24.1
7.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
18
30
9.60
11.46
2.4
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
17
33
7.87
9.30
3.9
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
20
48
6.92
8.90
2.5
2.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
24
69
6.61
8.85
10.0
4.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
13
20
8.88
8.61
4.2
2.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
27
92
6.20
8.13
38.2
7.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
12
10.56
7.91
2.3
1.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
25
87
5.48
7.14
13.0
3.2
e6/l
0.4
0.5
0.14
20
57
(36304419) Bacteria [Presence] in Urine
25
87
5.48
7.14
13.0
3.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
12
22
7.18
6.72
33.3
4.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
29
120
5.35
6.58
24.3
6.7
mmol/l
1.2
1.2
1.45
29
108
(3018095) Leukocytes [#/volume] in Urine
28
114
5.17
6.45
14.6
3.7
e6/l
39.1
12.8
0.40
19
71
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
6
0
+∞
6.39
2.3
0.0
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
6
0
+∞
6.39
3.2
0.0
—
—
—
0
0
(3000492) Spirometry study
13
29
5.99
5.98
2.7
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
20
66
4.80
5.90
4.8
2.2
mg/l
3.0
2.9
0.06
20
54
(3002582) Erythrocytes [#/volume] in Urine
25
99
4.64
5.82
13.0
3.0
e6/l
18.1
13.2
0.20
19
68
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
18
55
4.91
5.82
3.4
2.8
ng/l
4028.5
131.7
0.46
13
37
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
27
115
4.62
5.68
2.8
1.8
pmol/l
94.1
103.3
0.73
16
52
(21494814) CD8 cells/100 lymphocytes in Specimen
5
0
+∞
5.30
2.4
0.0
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
5
0
+∞
5.30
2.4
0.0
%
10.0
—
—
5
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
25
106
4.25
5.17
13.6
3.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
18
61
4.36
5.01
10.2
2.5
e6/l
0.5
0.7
—
10
31
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
7
13.64
5.01
1.6
2.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
17
57
4.28
4.77
10.5
2.6
e6/l
3.1
3.0
—
9
27
(3024561) Albumin [Mass/volume] in Serum or Plasma
27
127
4.03
4.70
9.7
4.5
g/l
35.3
35.9
0.22
27
121
(46235355) HIV 1 and 2 tests - Meaningful Use set
19
71
4.00
4.58
2.2
1.8
—
—
—
0
0
(4010399)
11
27
5.13
4.47
1.7
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
25
116
3.76
4.36
10.1
3.5
u/l
33.6
26.7
1.03
25
105
(3014007) Fractional oxyhemoglobin in Arterial blood
8
10
9.50
4.27
8.4
3.8
%
95.3
95.3
—
8
10
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
8
11
8.63
4.06
8.4
3.5
%
0.9
1.4
—
8
11
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
8
11
8.63
4.06
8.4
3.5
%
0.6
0.7
—
8
11
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
8
11
8.63
4.06
7.3
10.7
mmol/l
24.6
25.0
—
8
11
(3020630) Protein [Mass/volume] in Serum or Plasma
10
25
4.91
3.95
7.5
1.4
g/l
66.6
67.0
—
10
25
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
8
12
7.89
3.87
7.4
2.3
mmol/l
24.0
25.7
—
8
12
(40768443) Skin Pathology biopsy report
8
13
7.27
3.69
1.3
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
13
43
3.90
3.61
1.1
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
22
106
3.20
3.42
12.2
4.5
inr
1.4
1.1
—
6
33
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
11
7.35
3.33
1.7
1.8
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
11
7.35
3.33
1.7
1.8
—
—
—
0
0
(3036489) Thrombin time
6
8
8.47
3.16
6.3
8.0
s
22.3
21.0
—
6
8
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
6
8
8.47
3.16
2.3
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
8
17
5.52
3.09
39.6
9.4
kpa
4.8
4.9
—
8
17
(3004588) Protein electrophoresis panel - Serum or Plasma
9
22
4.88
3.09
7.7
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
5
11.06
3.05
57.8
13.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
18
82
3.06
3.01
6.7
3.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
13
6.19
3.00
1.3
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
34
227
3.37
2.96
4.4
3.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
7
14
5.74
2.86
9.3
1.0
g/l
40.7
37.3
—
7
14
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
7
14
5.74
2.86
9.3
1.0
g/l
0.0
0.0
—
7
14
(3009445) Proteinase 3 Ab [Units/volume] in Serum
7
14
5.74
2.86
2.0
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
14
5.74
2.86
9.3
1.0
g/l
7.2
8.2
—
7
14
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
14
5.74
2.86
9.3
1.0
g/l
9.4
10.7
—
7
14
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
7
14
5.74
2.86
9.3
1.0
g/l
3.1
0.7
—
7
14
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
14
5.74
2.86
7.0
5.5
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
7
14
5.74
2.86
9.3
1.0
g/l
0.0
0.0
—
7
14
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
14
5.74
2.86
9.3
1.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
14
5.74
2.86
9.3
1.0
g/l
3.0
3.3
—
7
14
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
14
5.74
2.86
9.3
1.0
g/l
3.3
4.1
—
7
14
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
7
14
5.74
2.86
44.0
8.6
mmol/l
25.9
25.3
—
7
14
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
7
14
5.74
2.86
9.3
1.0
g/l
0.0
0.0
—
7
14
(40768804) Tissue Pathology biopsy report
26
151
2.83
2.73
3.3
1.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
43
364
+∞
2.71
58.6
13.4
mmol/l
139.3
139.7
0.63
43
352
(3023103) Potassium [Moles/volume] in Serum or Plasma
43
365
+∞
2.71
59.3
13.4
mmol/l
3.9
4.0
0.15
43
351
(3014051) Protein [Presence] in Urine by Test strip
6
11
6.13
2.64
2.7
1.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
30
190
2.91
2.64
12.2
7.2
umol/l
10.9
10.4
0.13
30
182
(3034770) Mitochondria Ab [Titer] in Serum
5
7
7.88
2.62
1.0
1.1
—
—
—
0
0
(3012544) pH of Venous blood
9
27
3.93
2.57
37.6
6.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
9
27
3.93
2.57
36.4
6.6
mmol/l
2.1
3.3
—
9
21
(3020779) Urea [Moles/volume] in Serum or Plasma
8
22
4.22
2.51
7.1
9.5
mmol/l
9.6
8.2
—
8
22
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
8
6.89
2.44
1.2
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
8
6.89
2.44
1.0
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
16
76
2.76
2.41
3.9
2.2
mg/l
1.1
0.7
—
10
61
(3044640) Blood type and Crossmatch panel - Blood
20
108
2.59
2.33
3.0
2.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
34
243
2.90
2.28
10.4
4.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
10
5.49
2.13
1.4
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
10
5.49
2.13
1.2
1.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
10
5.49
2.13
2.4
1.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
17
88
2.54
2.13
15.2
2.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
35
259
2.88
2.12
4.1
3.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
8
27
3.40
2.06
2.4
2.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
16
82
2.51
2.03
2.5
2.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
16
4.18
2.01
2.7
2.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
16
4.18
2.01
2.7
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
6
16
4.18
2.01
1.2
1.3
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
5
11
4.98
2.00
1.2
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
26
170
2.34
1.90
9.7
4.8
estimate
0.0
0.0
—
5
30
(42529406) Shigella sp [Presence] in Stool by Culture
5
12
4.56
1.88
1.2
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
5
12
4.56
1.88
6.4
2.2
nmol/l
15.1
12.5
—
5
12
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
12
4.56
1.88
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
12
4.56
1.88
1.2
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
12
4.56
1.88
1.2
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
26
171
2.32
1.86
6.2
3.3
estimate
0.0
0.0
—
5
29
(3018677) aPTT in Platelet poor plasma by Coagulation assay
10
42
2.80
1.83
9.3
3.0
s
35.2
27.9
—
10
42
(3022145) Colonoscopy Study observation
8
30
3.04
1.83
1.8
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
26
172
2.29
1.82
6.3
3.3
estimate
0.0
0.0
—
5
29
(3003327) Ova and parasites identified in Stool by Light microscopy
5
13
4.20
1.76
1.4
1.5
—
—
—
0
0
(1002224) Polysomnography panel
6
19
3.49
1.73
1.0
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
7
26
3.01
1.66
2.6
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
22
3.00
1.49
1.2
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
19
119
2.07
1.44
4.4
3.3
mmol/l
2.3
2.4
0.46
14
100
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
16
98
2.01
1.26
1.5
1.8
mmol/l
1.7
1.4
0.49
16
79
(3009343) pH of Capillary blood
5
19
2.84
1.25
2.4
5.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
5
20
2.69
1.18
2.2
4.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
7
126
0.47
1.12
1.6
2.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
9
47
2.15
1.11
2.3
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
11
63
2.00
1.01
2.2
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
6
29
2.24
0.93
3.7
3.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
13
86
1.73
0.77
5.6
4.3
mg/mmol
36.0
7.2
—
8
55
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
16
113
1.66
0.76
3.6
2.7
ng/l
18.9
19.3
—
10
68
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
13
87
1.71
0.74
1.3
1.4
—
0.8
—
0
24
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
50
1.73
0.66
2.0
1.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
43
411
+∞
0.62
70.4
18.2
e9/l
265.0
260.0
0.12
43
404
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
54
1.59
0.61
2.1
2.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
13
93
1.57
0.57
1.5
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
13
93
1.57
0.57
3.1
3.0
—
—
—
0
0
(3015736) pH of Urine
18
139
1.51
0.56
6.8
2.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
11
76
1.60
0.55
12.0
5.7
—
—
—
0
0
(3002256) Pathology report gross observation
7
50
1.48
0.48
1.6
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.42
0.0
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
16
0.00
0.42
0.0
1.8
—
—
—
0
0
(3035941) MCH [Entitic mass]
43
412
+∞
0.41
69.6
18.1
pg
30.3
30.3
0.02
43
406
(3024731) MCV [Entitic volume]
43
412
+∞
0.41
69.6
18.1
fl
90.8
90.7
0.03
43
406
(3000963) Hemoglobin [Mass/volume] in Blood
43
412
+∞
0.41
70.3
18.2
g/l
131.5
136.0
1.11
43
406
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
7
52
1.41
0.33
1.4
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
20
170
1.33
0.33
3.7
3.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
38
1.36
0.24
1.4
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.4
—
292.6
—
0
5
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
8
75
1.08
0.08
1.3
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
14
128
1.14
0.08
4.4
3.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
10
108
0.90
0.03
1.5
1.4
—
—
—
0
0
(4094501)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
0.5
—
0
8
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(4034850)
0
6
0.00
0.00
0.0
34.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_AB_DEF_NORMHYPERIG and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have D3_AB_DEF_NORMHYPERIG.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: D3_AB_DEF_NORMHYPERIG – Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data